Alzheimer’S Therapeutics Market Poised For Growth: Projected To Surpass USD 10,433.9 ...
The growth of the Alzheimer's Disease Therapeutics Market is directly influenced by the increasing prevalence of Alzheimer's disease globally. The hi ...
Amneal Pharmaceuticals upgraded to Overweight from Neutral at JPMorgan
JPMorgan upgraded Amneal Pharmaceuticals (AMRX) to Overweight from Neutral with a price target of $12, up from $9. The firm cites the Crexont ...